Drug discovery company Enterprise Therapeutics Ltd. has successfully raised $2.4 million through a Series-A financing round. The company, based at the University of Sussex in the United Kingdom, is focused on creating novel therapies for respiratory diseases, such as cystic fibrosis (CF). A portion the funding will be invested in the…
News
PARI Respiratory Equipment, Inc. recently announced the enrollment of the first cystic fibrosis (CF) patient in its compressor access program called PARI PROVIDE, designed to support the launch of the Kitabis Pak. The product includes a combination of a drug and the device, which has already…
A phase 2 trial from Savara Pharmaceuticals investigating its lead product AeroVanc to treat methicillin-resistant Staphylococcus aureus (MRSA) infections in cystic fibrosis patients met a key primary endpoint. Patients treated with AeroVanc experienced a significant reduction in MRSA density in their…
In November, the Cystic Fibrosis Foundation sold their royalty rights for CF related drugs developed by Vertex Pharmaceuticals for $3.3 billion. The number is staggering and it was the largest sale of its kind, leaving the Foundation seemingly swollen with its sudden cash…
Could a change in diet to boost the immune system be helpful for treating cystic fibrosis? Researchers from the Czech Republic are betting on that possibility, and are currently enrolling volunteers for a clinical trial. Cystic fibrosis is one of the most commonly occurring chronic diseases of the lungs in…
Researchers at The University of British Columbia (UBC) recently opened a clinical trial designed to assess the sensation of shortness of breath or dyspnea in patients with cystic fibrosis (CF) during exercise. The study, titled “Qualitative Descriptors of Dyspnea During Exercise in Cystic Fibrosis”…
A study published in the journal Alcoholism: Clinical and Experimental Research revealed that the heavy drinking habits of lung donors can influence the outcome of lung transplantation in recipient patients. The study is entitled “Heavy Alcohol Use in Lung Donors…
Proteostasis Therapeutics, Inc. (PTI), a biotechnology company focused on discovering and developing novel small molecule therapeutics designed to control the body’s protein homeostasis, has just revealed a novel class of therapeutics called, CFTR Amplifiers, indicated for cystic fibrosis (CF). These agents work to enhance…
A new review on the impact of the microbiome in the upper airways on URTIs entitled, “The microbiome of the upper airways: focus on chronic rhino sinusitis” was recently published in the World Allergy Organization Journal by Thanit Chalermwatanachai, part of Dr. Claus…
My little sister, Jennifer, was a beautiful woman who, like myself, fought Cystic Fibrosis throughout her life and on Saturday, February 7, she passed away at twenty-three after her body rejected the set of lungs she had received by transplantation the previous October in Denver, Colorado. Cystic Fibrosis, like other…
Your CF Community
Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.